Navigation
Navigation
User login
Back to top

Conferences

Search conference abstracts from EUMDS.

Search
Displaying 83 results from 83 total publications.

van Zeventer et al. 2022.

Evolutionary landscape of clonal hematopoiesis revealed by longitudinal error-corrected sequencing in 3359 older community-based individuals

Isabelle A. van Zeventer,  Aniek O. De Graaf,  Jonas B. Salzbrunn,  Nolte, I,  Kamphuis, P,  Dinmohamed, AG,  Bert A. van der Reijden,  Jan Jacob Schuringa,  JH Jansen,  Gerwin Huls.

EHA Library
Volume: 366211; LB2368.

Garelius et al. 2022.

Erythropoietin stimulation agents significantly improves outcome in lower risk MDS

H Garelius,  Alexandra Smith,  Tim Bagguley,  Adele Taylor,  Pierre Fenaux,  David Bowen,  Argiris Symeonidis,  Moshe Mittelmann,  R Stauder,  Jaroslav Cermak,  Guillermo Sanz,  Saskia Langemeijer,  Luca Malcovati,  Ulrich Germing,  Raphael Itzykson,  A Guerci-Bresler,  Dominic Culligan,  Ioannis Kotsianidis,  K. Koinig,  C. Van Marrewijk,  Simon Crouch,  T de Witte,   Hellstrom-Lindberg.

HemaSphere
Volume: 6, Issue: S168, Pages: 69-70.

T. Silzle et al. 2021.

Lymphopenia is highly prevalent in MDS and provides prognostic information for IPSS-R (very)-low-risk patients. An analysis from the EU-MDS registry

T. Silzle,  , A. Taylor,  , T. de Witte,  , L. Malcovati,  , P. Fenaux5,  , D. Bowen,  A. Symeonidis,  R. Stauder,  J. Cermak,  G. Sanz,,  S. Langemeijer,  M. Skov Holm,  A. Savic,  E. Hellström-Lindberg,.

T. Silzle et al. 2021.

Lymphopenia is highly prevalent in MDS and provides prognostic information for IPSS-R (very)-low-risk patients. An analysis from the EU-MDS registry

T. Silzle,  , A. Taylor,  , T. de Witte,  , L. Malcovati,  , P. Fenaux5,  , D. Bowen,  A. Symeonidis,  R. Stauder,  J. Cermak,  G. Sanz,,  S. Langemeijer,  M. Skov Holm,  A. Savic,  E. Hellström-Lindberg,.

Swiss Medical Weekly
Volume: 151, Issue: Suppl.255, Pages: P28.

Efficace et al. 2021.

Validation of the Qualms Questionnaire to Assess Health-Related Quality of Life in European and Israeli Patients with Myelodysplastic Syndromes: Results from the MDS-Right Project

Fabio Efficace,  Karin A Koinig,  Francesco Cottone,  David Bowen,  Moshe Mittelman,  Saskia M. C. Langemeijer,  Dominic Culligan,  Kalman Filanovsky,  Gregory A. Abel,  Michael Storck,  Alexandra Smith,  Corine Van Marrewijk,  Martin Dugas,  Theo M de Witte,  Reinhard Stauder.

Blood
Volume: 138, Issue: Supplement 1, Pages: 1982.

Bowen et al. 2021.

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

David Bowen,  Adele Taylor,  Pierre Fenaux,  Agnes Guerci-Bresler,  Raphael Itzykson,  Argiris Symeonidis,  Ioannis Kotsianidis,  Moshe Mittelman,  Guillermo Sanz,  Dominic J. Culligan,  Jaroslav Cermak,  Reinhard Stauder,  Eva Hellstrom Lindberg,  Luca Malcovati,  Saskia M. C. Langemeijer,  Ulrich Germing,  Howard S. Oster,  Krzysztof Madry,  Mette Skov Holm,  Alexandra Smith,  Corine van Marrewijk,  Theo M de Witte.

Blood
Volume: 138, Issue: Supplement 1, Pages: 4671.

Silzle T, Taylor A, de Witte T, Malcovati L, Fenaux P, Bowen D, Symeonidis A, Mittelman M, Stauder R, et al. 2021.

Lymphopenia is highly prevalent in MDS and provides additional prognostic information for IPSS-R very-low and low-risk patients. An analyses from the EUMDS Registry.

Silzle T, Taylor A, de Witte T, Malcovati L, Fenaux P, Bowen D, Symeonidis A, Mittelman M, Stauder R,,  Cermak J, Sanz G, Hellström-Lindberg E, Langemeijer S, Holm MS, Madry K, Tatic A, Almeida AM, Savic A,,  Mandac Rogulj I, Germing U, Smith A.

Sandmann et al. 2021.

CooPer plots – the next level of UpSet plots

Sarah Sandmann,  Martin Dugas,  Julian Varghese.

F1000Research
Volume: 10.

Stojkov et al. 2020.

Longitudinal Study on Determinants of Health-Related Quality of Life in Patients with Myelodysplastic Syndromes

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Marjan Arvandi,  Karin A Koinig,  M Schomaker,  Pierre Fenaux,  David Bowen,  Argiris Symeonidis,  Moshe Mittelman,  Jaroslav Cermak,  Guillermo Sanz,  Eva Hellstrom Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  Mette Holm,  Krzysztof Madry,  A Guerci-Bresler,  Dominic Culligan,  Ioannis Kotsianidis,  Laurence Sanhes,  Juliet Mills,  Sibylle Puntscher,  D Schmid,  Corine Van Marrewijk,  Alexandra Smith,  T. M. de Witte,  Uwe Siebert,  Reinhard Stauder.

Blood
Volume: 136, Issue: S1, Pages: #1279.

Malcovati et al. 2020.

Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Luca Malcovati,  Simon Crouch,  Aniek O. De Graaf,  Sarah Sandmann,  Magnus Tobiasson,  Olivier Kosmider,  Bert A. van der Reijden,  Daniel Painter,  Arjan A. Van de Loosdrecht,  Argiris Symeonidis,  Jaroslav Cermak,  Emmanuelle Clappier,  Claude Preudhomme,  Reinhard Stauder,  Moshe Mittelman,  Ulrich Germing,  David Bowen,  Pierre Fenaux,  Corine Van Marrewijk,  Alexandra Smith,  Martin Dugas,  Eva Hellstrom Lindberg,  Theo M de Witte,  Michaela Fontenay,  Joop Jansen.

Blood
Volume: 136, Issue: S1.

Tekath and Dugas 2020.

DTUrtle – Differential transcript usage analysis for bulk and single-cell data

Tobias Tekath,  Martin Dugas.

F1000Research
Volume: 9, Issue: 861.

van Zeventer 2020.

Mutatiespectrum en dynamiek van klonale hematopoése bij ouderen met anemie

Isabelle A. van Zeventer.

Sandmann et al. 2020.

Analyzing coverage in smMIPs data

S Sandmann,  AO de Graaf,  JH Jansen,  M Dugas.

Stojkov et al. 2020.

Delphi-Survey-Based Development of Core Patient-Reported Outcomes in Myelodysplastic Syndromes

I. Stojkov,  A Conrads-Frank,  U Rochau,  KA Koinig,  M Arvandi,  S Puntscher,  C van Marrewijk,  P Fenaux,  T de Witte,  F Efficace,  U Siebert,  R Stauder.

Van de Loosdrecht 2020.

Diagnose en prognose van MDS

A. A. Van de Loosdrecht.

Stojkov et al. 2020.

Determinants of Health-Related Quality of Life in Patients with Myelodysplastic Syndromes

I. Stojkov,  A Conrads-Frank,  U Rochau,  M Arvandi,  KA Koinig,  M Schomaker,  S Puntscher,  D Schmid,  C van Marrewijk,  A. Smith,  T de Witte,  F Efficace,  R Stauder,  U Siebert.

Sandmann and Dugas 2019.

How to “appreci8” Variant Calling in NGS Data

Sarah Sandmann,  Martin Dugas.

F1000Research
Volume: 8.

Stojkov et al. 2019.

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

K Stojkov,  T Silzle,  G Stussi,  D Schwappach,  J Bernhard,  D Bowen,  J Cermák,  A Dinmohamed,  C Eeltink,  S Eggmann,  P Fenaux,  U Germing,  M Haschke,  E Hellstrom-Lindberg,  M Heger,  AA van de Loosdrecht,  J Passweg,  M Pfeilstöcker,  U Platzbecker,  L Malcovati,  AM Almeida,  M Mittelman,  C Morgenthaler,  D Steensma,  V Santini,  R Stauder,  A Symeonidis,  S Schaer,  C, Maddox,  T de Witte,  J Bohlius,  N Bonadies,  Swiss Group of Clinical Cancer Research (SAKK).

Blood
Volume: 134.

Tekath and Dugas 2019.

DTUrtle – an easily accessible Differential Transcript Usage analysis pipeline

Tobias Tekath,  Martin Dugas.

F1000Research
Volume: 8.

Sandmann and Dugas 2019.

appreci8R: an R package for calling variants the "appreci8"-way</p>

Sarah Sandmann,  Martin Dugas.

F1000Research
Volume: 8.

Duetz et al. 2019.

Artificial intelligence for flow cytometry data analysis in suspected-MDS enables an accurate, objective and fast diagnosis

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  Yvan Saeys,  A. A. Van de Loosdrecht.

Wünsch and Dugas 2019.

AMLVaran: Improvements in user-friendlyness of a human NGS variant assessment system</p>

Christian Wünsch,  Martin Dugas.

F1000Research
Volume: 8.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.


Pages: S838.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes. S838

Marlijn Hoeks,  Timothy Bagguley,  R. Roelofs,  L. Swart,  David Bowen,  Argiris Symeonidis,  Corine van Marrewijk,  E. Hellstrom-Lindberg,  A. Tatic,  S. Langemeijer,  D. Culligan,  Mac Macheta,  H. Garelius,  M. Spanoudakis,  S. Killick,  P. Panagiotidis,  Stanca Ciocan,  J. Mills,  B. Pottinger,  T. Witte.


Volume: 3, Pages: 373.

Hoeks et al. 2019.

Transfusie-afhankelijkheid is geassocieerd met de aanwezigheid van toxische ijzersoorten en slechtere overleving bij patiënten met een laag-risico myelodysplastisch syndroom

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.

Duetz et al. 2019.

Computational flow cytometry: a novel diagnostic tool in myelodysplastic syndromes

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  A. A. Van de Loosdrecht.

Oster et al. 2019.

A Web Application Could Help Diagnose or Exclude MDS, Providing a Noninvasive Alternative to Bone Marrow Examination

H Oster,  S Crouch,  A Smith,  G Yu,  J Ben-Ezra,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Guerci-Bresler,  D Culligan,  S Laurence,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

de Witte et al. 2019.

New prognostic indicators in MDS identified during the first 10 years of the EUropean LeukemiaNet MDS (EUMDS) Registry

T de Witte,  P Fenaux,  D Bowen,  A Symeonidis,  M Mittelman,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Tatic,  AM Almeida,  A Savic,  N Gredelj Šimec,  R Itzykson,  D Culligan,  I Kotsianidis,  L Ades,  AA van de Loosdrecht,  C van Marrewijk,  G Yu,  S Crouch,  L Malcovati,  A Smith.

Leukemia Research
Volume: 90.

Oster et al. 2019.

A Web Application Could Help in MDS Diagnosis and Obviate the Bone Marrow Examination

H Oster,  S Crouch,  A Smith,  G Yu,  B Abu Shrkihe,  B Shoham,  A Kolomansky,  J Ben-Ezra,  S Naor,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  U Germing,  MS Holm,  A Guerci-Bresler,  D Culligan,  S Laurence,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

Leukemia Research
Volume: 144.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.


Volume: 114, Pages: P-522.

Duetz et al. 2019.

Artificial intelligence improves flow cytometry in myelodysplastic syndromes

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  Yvan Saeys,  Arjan A. Van de Loosdrecht.

Patton et al. 2018.

Identifying Multinational Cost Data: A Methodological Review and Case Study

Thomas Patton,  CM Hung,  M Henriksson,  M Huic,  AP Marques,  S Puntscher,  D Vukicevic,  M Ruggeri,  A Manca.

Madry et al. 2018.

Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death

K Madry,  G Yu,  K Lis,  P Fenaux,  D Bowen,  A Symeonidis,  M Mittelman,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  A Guerci-Bresler,  D Culligan,  L Sanhes,  J Mills,  I Kotsianidis,  C van Marrewijk,  S Couch,  T de Witte,  A Smith.

Blood
Volume: 132.

Oster et al. 2018.

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

HS Oster,  S Crouch,  A Smith,  G Yu,  B Abu Shrkihe,  S Baruch,  A Kolomansky,  J Ben-Ezra,  S Naor,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermak,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Guerci-Bresler,  D Culligan,  L Sanhes,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

Blood
Volume: 132.

Hoeks et al. 2018.

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellström-Lindberg,  A Tatic,  S Langemeijer,  DJ Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  DW Swinkels,  TM de Witte.

Blood
Volume: 132, Issue: S1.

Stauder et al. 2018.

Longitudinal Changes of Impairments in Health-Related Quality of Life in Lower-Risk MDS Patients: A European Leukemianet Study

R. Stauder,  G. Yu,  K. A. Koinig,  D. Culligan,  P. Fenaux,  J. Cermak,  A. Symeonidis,  T. Bernal,  E. Hell-Strom-Lindberg,  M. Mittelman,  S. Langemeijer,  M. S. Holm,  J. Mills,  A. Guerci-Bresler,  C. van Marrewijk,  H. Garelius,  F. Efficace,  A. Smith,  D. Bowen,  T. M. de Witte.

Blood
Volume: 132.

Stojkov et al. 2018.

Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin A Koinig,  Helena Borba,  Marjan Arvandi,  Pierre Fenaux,  Argiris Symeonidis,  David Bowen,  Moshe Mittelman,  Corine van Marrewijk,  Theo de Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.

Blood
Volume: 132, Issue: Supplement 1, Pages: 2295.

Stojkov et al. 2018.

Developing a Core Outcome Set for Myelodysplastic Syndromes - an International Delphi Survey

Igor Stojkov,  Ursula Rochau,  Conrads-Frank Annette,  Karin Koinig,  Marjan Arvandi,  Argiris Symeonidis,  Sanz Guillermo,  Pierre Fenaux,  David Bowen,  Moshe Mittelmann,  Hege Garelius,  Ulrich Germing,  Corine van Marrewijk,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Alex Smith,  Theo de Witte,  Fabio Efficace,  Reinhard Stauder,  Uwe Siebert.


Volume: PS4-31, Pages: PS4-31.

Stojkov et al. 2018.

DEVELOPING A CORE OUTCOME SET FOR MYELODYSPLASTIC SYNDROMES – THE MDS-RIGHT HEALTH PROFESSIONAL DELPHI SURVEY

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin Koinig,  Marjan Arvandi,  Argiris Symeonidis,  Sanz Guillermo,  Pierre Fenaux,  David Bowen,  Moshe Mittelman,  Hege Garelius,  Ulrich Germing,  Corine Van Marrewijk,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Alexandra Smith,  Theo de Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.


Pages: PB2100.

Stojkov et al. 2018.

Systematic Overview of Patient-Reported Outcomes for Myelodysplastic Syndromes

Igor Stojkov,  Ursula Rochau,  Conrads-Frank Annette,  Helena Borba,  Karin Koinig,  Marjan Arvandi,  Fabio Efficace,  Reinhard Stauder,  Uwe Siebert.

de Swart et al. 2018.

Impact of Red Blood Cell Transfusion Rate, Adjusted by Therapeutic interventions, on Progression-Free Survival in Lower-Risk MDS Patients within the European LeukemiaNet MDS Registry

L. de Swart,   Hoeks, M.,  S. Crouch,  A. Smith,  S. Langemeijer,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hell-Strom-Lindberg,  R. Stauder,  G. Sanz,  M. Mittelman,  M. S. Holm,  L. Malcovati,  K. Madry,  U. Germing,  A. Savic,  A. M. Almeida,  A. Guerci-Bresler,  R. Itzykson,  O. Beyne-Rauzy,  D. Culligan,  C. van Marrewijk,  N. M. A. Blijlevens,  D. Bowen,  T. M. de Witte.


Volume: 215537, Pages: PS1233.

Duetz et al. 2018.

Computational flow cytometry: a diagnostic tool in MDS

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  A. A. Van de Loosdrecht.

Hoeks, M. et al. 2018.

Impact van behandeling met ijzerchelatietherapie op patiënten met een laag-risico myelodysplastisch syndroom die deelnemen aan de Europese MDS registratie

Hoeks, M.,  G. Yu,  S. Langemeijer,  S. Crouch,  L. de Swart,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hell-Strom-Lindberg,  G. Sanz,  R. Stauder,  M. Skov Holm,  M. Mittelman,  K. Madry,  L. Malcovati,  A. Tatic,  A. M. Almeida,  U. Germing,  A. Savic,  N. Gredelj Šimec,  D. Culligan,  R. Itzykson,  A. Guerci-Bresler,  B. Slama,  C. Van Marrewijk,  J. Droste,  M. van Kraaij,  D. Bowen,  T. M. de Witte,  A. Smith.

Verwimp-Hoeks et al. 2017.

Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Marlijn Verwimp-Hoeks,  Ge Yu,  Saskia Langemeijer,  Simon Crouch,  L. Swart,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Mette Holm,  Moshe Mittelman,  K. Madry,  Luca Malcovati,  A. Tatic,  Antonio Almeida,  Ulrich Germing,  Aleksandar Savic,  Alex Smith.

Oster et al. 2017.

Can We Diagnose MDS without Bone Marrow Examination? a Proposed EUMDS-Based Non-Invasive Diagnostic Model

Howard Oster,  Bander Shrkihe,  Simon Crouch,  Alexandra Smith,  Ge Yu,  Gal Carmi,  Jona-Than Ben-Ezra,  Shachar Naor,  Pierre Fenaux,  Argiris Symeonidis,  Reinhard Stauder,  Jaroslav Cer-Mak,  Guillermo Sanz,  Eva Hellstrom-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  Skov Mette,  Mette Holm,  Moshe Mittelman.

Symeonidis et al. 2017.

The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS). a Study of the European LeukemiaNet-Based MDS (EUMDS) Registry

Argiris Symeonidis,  Ge Yu,  Alexandra Smith,  Pierre Fenaux,  Moshe Mittelman,  Reinhard Stauder,  Guillermo Sanz,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  K. Madry,  Skov Mette,  Mette Holm,  A. Tatic,  Antonio Almeida,  Alek-Sandar Savic,  Njetocka Gredelj,  David Bowen.

Itzykson et al. 2017.

A Prognostic Classifier Based on Early Platelet Drop in Lower-Risk MDS. a Study from the European LeukemiaNet Lower-Risk MDS (EUMDS) Registry

Raphael Itzykson,  Simon Crouch,  Alex Smith,  Argiris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Moshe Mittelman,  Saskia Langemeijer,  K. Madry,  A. Tatic,  Skov Mette,  Mette Holm,  Antonio Almeida,  Aleksandar Savic,  Njetocka Gredelj,  Pierre Fenaux.

Swart et al. 2017.

Impact of Red Blood Cell Transfusion Intensity on Progression-Free Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS Registry

L. Swart,  Simon Crouch,  Marlijn Verwimp-Hoeks,  Alex Smith,  Saskia Langemeijer,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Reinhard Stauder,  Moshe Mittelman,  Guillermo Sanz,  Eva Hell-Strom-Lindberg,  Luca Malcovati,  Skov Mette,  Mette Holm,  Ulrich Germing,  K. Madry,  Antonio Almeida,  A. Tatic,  T Witte.

de Swart et al. 2017.

280 - Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry

L. de Swart,  S. Crouch,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hellström-Lindberg,  G. Sanz,  R. Stauder,  L. Malcovati,  U. Germing,  S. Langemeijer,  M. Skov Holm,  M. Mittelman,  K. Madry,  A. Almeida,  A. Savic,  R. Itzykson,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S160-S161.

Stauder et al. 2017.

22 - Health-Related Quality of Life is Substantially Impaired in Lower-Risk MDS when Compared with Reference Populations and Significantly Affects Overall Survival

R. Stauder,  G. Yu,  K. Koinig,  P. Fenaux,  A. Symeonidis,  G. Sanz,  J. Cermak,  M. Mittelman,  E. Hellström-Lindberg,  S. Langemeijer,  M. Skov Holm,  K. Madry,  L. Malcovati,  A. Tatic,  U. Germing,  A. Savic,  F. Efficace,  A. Smith,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S12.

Itzykson et al. 2017.

19 - Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry

R. Itzykson,  A. Smith,  P. Fenaux,  A. Symeonidis,  M. Mittelman,  R. Stauder,  G. Sanz,  J. Cermák,  E. Hellström-Lindberg,  L. Malcovati,  S. Langemeijer,  U. Germing,  K. Madry,  M. S. Holm,  A. Tatic,  A. M. Almeida,  A. Savic,  N. Gredelj Šimec,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S10-S11.

Langemeijer et al. 2016.

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European LeukemiaNet MDS (EUMDS) Registry

Saskia Langemeijer,  L. Swart,  Ge Yu,  Alex Smith,  Simon Crouch,  W Thomas Johnston,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Mette Holm,  Moshe Mittelman,  K. Madry,  A. Tatic,  Antonio Almeida,  Theo Witte.

Hoeks et al. 2016.

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Marlijn Hoeks,  Saskia Langemeijer,  Louise De Swart,  Tim Bagguley,  Corine van Marrewijk,  David Bowen,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Marian G. J. Van Kraaij,  Panagiotis Panagiotidis,  Hege Garelius,  Dominic J. Culligan,  Marta Krejci,  Jackie Droste,  Alexandra Smith,  Dorine W. Swinkels,  Theo de Witte.

Blood
Volume: 128, Issue: 22, Pages: 4327-4327.

Langemeijer et al. 2016.

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Saskia Langemeijer,  Louise De Swart,  Ge Yu,  Alex Smith,  Simon Crouch,  Tom Johnston,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Mette Skov Holm,  Moshe Mittelman,  Krzysztof Madry,  Aurelia Tatic,  Antonio Almeida,  Aleksandar Savic,  Sophie Park,  Odile Beyne-Rauzy,  Raphaël Itzykson,  Corine van Marrewijk,  David Bowen,  Theo de Witte.

Blood
Volume: 128, Issue: 22, Pages: 3186-3186.

Stauder et al. 2016.

Comparison of 1690 MDS Patients from the European Leukemianet Registry and Reference Populations - Evidence for a Significant Impairment in Qol in MDS and Definition of Predictors of Diminished Qol

R. Stauder,  G. Yu,  T. Bagguley,  P. Fenaux,  A. Symeonidis,  G. Sanz,  J. Cermak,  M. Mittelman,  E. Hellstrom-Lindberg,  S. Langemeijer,  M. S. Holm,  K. Madry,  L. Malcovati,  A. Tatic,  U. Germing,  A. Savic,  C. van Marrewijk,  A. Guerci-Bresler,  E. Luno,  J. Droste,  K. Koinig,  A. Smith,  D. Bowen,  T. de Witte.

Haematologica
Volume: 101, Pages: 16-17.

De Swart et al. 2015.

Prognostic Impact of Transfusions Intensity on Survival and Development of Thrombocytopenia in Newly Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet EU-MDS Registry

Louise De Swart,  Tom Johnston,  Alexandra Smith,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Gerwin Huls,  Mette Skov Holm,  Moshe Mittelman,  Krzysztof Madry,  Aurelia Tatic,  Antonio Medina Almeida,  Aleksandar Savic,  Sophie Park,  Odile Beyne-Rauzy,  Raphaël Itzykson,  Corine van Marrewijk,  David Bowen,  Theo de Witte.

Blood
Volume: 126, Issue: 23, Pages: 1677-1677.

De Swart et al. 2015.

Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart,  Chloé Reiniers,  Tim Bagguley,  David Bowen,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Gerwin Huls,  Panagiotis Panagiotidis,  Hege Garelius,  Dominic Culligan,  Marta Krejci,  Corine van Marrewijk,  Jackie Droste,  Alexandra Smith,  Dorine W. Swinkels,  Theo de Witte.

Blood
Volume: 126, Issue: 23, Pages: 2865-2865.

de Swart et al. 2015.

Transfusions and Presence of Ringsideroblasts Influence Hepcidin and NTBI Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) - a Report from the European Leukemianet MDS Registry

L. de Swart,  C. Reiniers,  T. Bagguley,  C. Van Marrewijk,  D. Bowen,  J. Cermak,  E. Hellström-Lindberg,  A. Tatic,  A. Symeonidis,  G. Huls,  P. Panagiotidis,  H. Garelius,  D. Culligan,  M. Krejci,  J. Droste,  A. Smith,  D. Swinkels,  T. de Witte.

Leukemia Research
Volume: 39, Pages: S106-S107.

de Swart et al. 2015.

Prognostic Impact of Transfusion Intensity on Survival and Thrombocytopenia in Newly Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

L. de Swart,  W. T. Johnston,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hellström-Lindberg,  G. Sanz,  R. Stauder,  L. Malcovati,  U. Germing,  G. Huls,  M. S. Holm,  M. Mittelman,  K. Madry,  A. Tatic,  A. M. Almeida,  A. Savic,  S. Park,  O. Beyne-Rouzy,  R. Itzykson,  J. Droste,  D. Bowen,  T. de Witte.


Volume: 39, Pages: S23-S24.

Stauder et al. 2015.

Determinants of Health-Related Quality of Life in Elderly MDS-Patients - A study from the European LeukemiaNet MDS Registry

R. Stauder,  T. Bagguley,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  G. Sanz,  E. Hellstrom-Lindberg,  M. Mittelman,  L. Malcovati,  G. Huls,  K. Madry,  U. Germing,  A. Tatic,  M. Skov Holm,  A. Savic,  J. Droste,  A. Guerci-Bresler,  B. Slama,  E. Luno,  D. Culligan,  L. De Swart,  T. Johnston,  D. Bowen,  T. de Witte.

SIOG

Stauder et al. 2015.

Impact of MDS on Health-Related Quality of Life: A Comparison of IPSS Low-and Int-1 Risk MDS Patients from the European Leukemianet MDS (EUMDS) Registry and European Reference Populations

R. Stauder,  T. Bagguley,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  G. Sanz,  E. Hellstrom-Lindberg,  M. Mittelman,  L. Malcovati,  G. Huls,  K. Madry,  U. Germing,  A. Tatic,  M. S. Holm,  A. Savic,  J. Droste,  A. Guerci-Bresler,  B. Slama,  E. Luno,  D. Culligan,  L. De Swart,  W. T. Johnston,  D. Bowen,  T. de Witte.

Haematologica
Volume: 100.

De Swart et al. 2014.

Hepcidin and GDF15 Levels during the First 2 Years Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart,  Chloé Reiniers,  Tim Bagguley,  Corine van Marrewijk,  David Bowen,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Gerwin A. Huls,  Alex Smith,  Theo de Witte.

Blood
Volume: 124, Issue: 21, Pages: 3267-3267.

Reiger et al. 2014.

Assessment of quality of life – a comparison of a German reference population a cohort from an Innsbruck senior fair and MDS-patients

A. Reiger,  G. Kemmler,  V. Bach,  S. Burgstaller,  L. de Swart,  A. Smith,  D. Bowen,  P. Fenaux,  T. de Witte,  R. Stauder.

Frühjahrstagung

Swart et al. 2013.

Validation Of The Revised International Prognostic Scoring System (IPSS-R) In 1000 Newly Diagnosed MDS Patients With Low- and Intermediate-1 Risk MDS In The European Leukemianet MDS (EUMDS) Registry

Louise de Swart,  Alex Smith,  Tom Johnston,  Detlef Haase,  Jackie Droste,  Pierre Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  Eva Hellström-Lindberg,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Antonio Medina Almeida,  Krzysztof Madry,  Borhane Slama,  Agnès Guerci-Bresler,  Laurence Sanhes,  Odile Beyne-Rauzy,  Elisa Luño,  David Bowen,  Theo de Witte.

Blood
Volume: 122, Issue: 21, Pages: 2770-2770.

Garelius et al. 2013.

European distribution of usage and impact on outcome for treatment with erythropoietic stimulating agents within the EUMDS lower-risk registry programme

H. Garelius,  W. T. Johnston,  A. A. Van de Loosdrecht,  S. Park,  L. De Swart,  R. Stauder,  A. Symeonidis,  G. Sanz,  J. Cermak,  O. Georgescu,  M. Skov-Holm,  U. Germing,  P. Fenaux,  M. MacKenzie,  L. Malcovati,  K. Madry,  A. M. Antonio Medina Almeida,  D. Bowen,  T. De Witte,  A. Smith,  E. Hellström-Lindberg.

Leukemia Research
Volume: 37, Pages: S21-S22.

Garelius et al. 2013.

European pattern and impact of the use of erythropoietic agents (ESAs) in low and int-1 risk with propensity scoring techniques in observational longitudinal studies

H. Garelius,  W. T. Johnston,  A. A. Van de Loosdrecht,  S. Park,  L. de Swart,  R. Stauder,  A. Symeonidis,  G. Sanz,  J. Cermak,  O. Georgescu,  M. Skov Holm,  U. Germing,  P. Fenaux,  M. MacKenzie,  L. Malcovati,  K. Madry,  A Medina Almeida,  D. Bowen,  T. de Witte,  A. Smith,  E. Hellstrom-Lindberg.

Haematologica
Volume: 98, Pages: 87-88.

Stauder et al. 2013.

A longitudinal observational study on the health-related quality of life in IPSS low-risk MDS - impact of time course and transfusion need

R. Stauder,  T. Jonston,  A. Smith,  P. Fenaux,  J. Droste,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. MacKenzie,  O. Beyne-Rauzy,  L. Malcovati,  A. Guerci,  L. Sanhes,  B. Iama,  E. Luno,  D. Bowen,  T. de Witte.

Haematologica
Volume: 98, Pages: 81.

de Swart et al. 2012.

Early Mortality in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European Leukemianet MDS (EUMDS) Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  Guillermo Sanz,  Eva Hellstrom-Lindberg,  Argyris Symeonidis,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Krzysztof Madry,  Sophie Park,  Odile Beyne-Rauzy,  Jackie Droste,  David Bowen,  Theo de Witte.

Blood
Volume: 120, Issue: 21, Pages: 3830-3830.

Itzykson et al. 2012.

Prognostic Relevance of the Kinetics of Worsening of Cytopenias in Lower-Risk MDS: A Substudy From the European Leukemianet Low Risk MDS (EUMDS) Registry

Raphael Itzykson,  Alex Smith,  Theo M. de Witte,  Jackie Droste,  Reinhard Stauder,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Mette Skov-Holm,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  David Bowen,  Pierre Fenaux.

Blood
Volume: 120, Issue: 21, Pages: 700-700.

de Swart et al. 2011.

Transfusion-Dependency Is the Most Important Prognostic Factor for Survival in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European LeukemiaNet MDS Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  David Bowen,  Guillermo Sanz,  Eva Hellström-Lindberg,  Argyris Symeonidis,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Sophie Park,  Odile Beyne-Rauzy,  Jackie Droste,  Theo de Witte.

Blood
Volume: 118, Issue: 21, Pages: 2775-2775.

Stauder et al. 2011.

Health-related quality of life in low-risk MDS patients from the European LeukemiaNet Registry: Correlation with age, gender and decreased survival

R. Stauder,  A. Smith,  T. de Witte,  J. Proste,  P. Fenaux,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. Mac Kenzie,  O. Beyne-Rauzy,  L. Malcovati,  D. Bowen.

Leukemia Research
Volume: 35, Pages: S12.

de Swart et al. 2011.

Management of 1000 patients with low- and intermediate-1 risk myelodysplastic syndromes in the European LeukemiaNet MDS Registry

L. de Swart,  A. Smith,  P. Fenaux,  A. Symeonidis,  E. Hellström-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. MacKenzie,  O. Beyne-Rauzy,  L. Malcovati,  R. Stauder,  J. Droste,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 35, Pages: S3.

de Swart et al. 2010.

Disease-Management of Low- and Intermediate-1 Risk Myelodysplastic Syndromes: Report on 800 Newly Diagnosed MDS Patients From the European LeukemiaNet MDS Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellström-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  Reinhard Stauder,  Jackie Droste,  David Bowen,  Theo de Witte.

Blood
Volume: 116, Issue: 21, Pages: 2917-2917.

Stauder et al. 2010.

Health-Related Quality of Life In Newly Diagnosed Low Risk and Intermediate-1 Risk MDS: Report on the First 683 Patients From the European LeukemiaNet Registry

Reinhard Stauder,  Alex Smith,  Theo de Witte,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo F. Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  David Bowen.

Blood
Volume: 116, Issue: 21, Pages: 3999-3999.

Bowen et al. 2010.

The Population-Based ‘real world’ of Low Risk Myelodysplastic Syndromes; Second Interim Analysis of the European LeukemiaNet MDS Registry at 800 Registered New Patients

David Bowen,  Alex Smith,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo F. Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Reinhard Stauder,  Odile Beyne-Rauzy,  Luca Malcovati,  Theo de Witte.

Blood
Volume: 116, Issue: 21, Pages: 1867-1867.

Stauder et al. 2010.

Assessment of Health-Related Quality of Life at Diagnosis in an European Registry for Low Risk and Intermediate-1 Risk MDS: Report of the first 322 patients

R. Stauder,  A. Smith,  T. de Witte,  J. Droste,  P. Fenaux,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  M. MacKenzie,  O. Beyne-Rauzy,  D. Bowen.

Haematologica
Volume: 95, Pages: 131-132.

de Witte et al. 2009.

European Registry for Low Risk and Intermediate-1 Risk MDS: Base Line Report On First 400 Registered Patients.

T. M. de Witte,  Alex Smith,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Reinhard Stauder,  Odile Beyne Rauzy,  David T. Bowen.

Blood
Volume: 114, Issue: 22, Pages: 3811-3811.

Bowen et al. 2009.

European LeukemiaNet registry programme for low/INT1 IPSS score myelodysplastic syndromes

David Bowen,  Jacqueline Droste,  Alexandra Smith,  P. Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  E. Hellström-Lindberg,  J. Cermak,  Radu Gologan,  U. Germing,  Reinhard Stauder,  L. Malcovati.

Leukemia Research - LEUK RES
Volume: 33.

Stojkov et al.

CONSENSUS SET OF CORE PATIENT-REPORTED OUTCOMES FOR MYELODYSPLASTIC... by Igor Stojkov

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin A Koinig,  Marjan Arvandi,  Sibylle Puntscher,  Corine van Marrewijk,  Pierre Fenaux,  Argiris Symeonidis,  Fatiha Chermat,  Hege Garelius,  David Bowen,  Moshe Mittelman,  Elvira Mora,  T. De Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.


Volume: EP817.

Wouters et al.

THE ANEMIA-INDEPENDENT EFFECT OF MYELODYSPLASTIC SYNDROMES ON... by Hanneke Wouters

Hanneke Wouters,  Annette Conrads-Frank,  Karin A Koinig,  Alex Smith,  Ge Yu,  Theo de Witte,  Bruce H. R. Wolffenbuttel,  Gerwin Huls,  Uwe Siebert,  Reinhard Stauder,  Melanie M. van der Klauw.

Stojkov et al.

ASSESSING THE DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE IN... by Igor Stojkov

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Marjan Arvandi,  Karin A Koinig,  M Schomaker,  Sibylle Puntscher,  D Schmid,  Corine van Marrewijk,  Alex Smith,  Theo de Witte,  Uwe Siebert,  Reinhard Stauder.

Garelius et al.

IMPACT OF ERYTHROPOIETIN STIMULATION AGENTS AND RED BLOOD CELL... by Dr. Hege Garelius

Hege Garelius,  Alex Smith,  Simon Appleton,  David Bowen,  Pierre Fenaux,  Argiris Symeonidis,  Moshe Mittelman,  Reinhard Stauder,  Jaroslav Cermak,  Guillermo Sanz,  Saskia Langemeijer,  Mette Skov Holm,  Raphael Itzykson,  Dominic Culligan,  Sonja Heibi,  Juliet Mills,  T. Bernal,  Ioannis Kotsianidis,  Lionel Ades,  Karin A Koinig,  Corine van Marrewijk,  Simon Crouch,  T. De Witte,  Eva Hellstrom Lindberg.